Mechanisms and Preclinical Discovery: Inflammation, fibrosis and cardiovascular function: new insights into old concepts
Tracks
Track 3
| Friday, August 7, 2026 |
| 3:45 PM - 5:15 PM |
Speaker
Timothy McKinsey
ISHR President's Distinguished Lecture: Signaling and epigenetics in heart failure: From academics to industry and back
3:45 PM - 4:30 PMBiography
Judith Sluimer
Elucidating the role of inflammatory and fibrotic cellular players in vascular pathologies
4:30 PM - 4:45 PMBiography
Dr Daniel Donner
Head of Translational Cardiology Centre
Baker Heart and Diabetes Institute
Anti-CD14 antibody therapy for STEMI
5:00 PM - 5:15 PMBiography
Daniel Donner is the founder and Head of the Translational Cardiology Centre at the Baker Institute. His research programs span drug and device development across heart attack and cardiac arrest, and he leads a genuinely translational research team of postdocs, cardiologists, surgeons, interventionalists, anaesthetists, intensivists, sonogragraphers, veterinarians and PhD students.
